Peptides DB
Research-centric peptide and protocol reference hub
Study 36 of 47NAD+ (Nicotinamide Adenine Dinucleotide) literaturePlatelets · Observational2026

The mitochondrial deacetylase SIRT3 is nonessential for cyclophilin D-dependent procoagulant platelet formation in mice.

SIRT3 is not required for procoagulant platelet formation, indicating that platelets may rely on different mechanisms for activation.

Read at PlateletsAdd to compare

Where it sits

this study against the rest of the nad+ (nicotinamide adenine dinucleotide) corpus
17
Preclinical
23
Observational · this one
1
Open-label
1
Randomised
5
Reviews

Summary and findings

This study investigated the role of SIRT3 in procoagulant platelet formation using platelets from Sirt3 knockout mice and littermate controls. The findings indicated that SIRT3 does not alter mitochondrial respiration or procoagulant platelet generation in response to agonist stimulation. No specific dose was reported.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.2026

Abstract

The authors’ words, as Platelets supplied them

Sirtuin 3 (SIRT3) is a nicotinamide adenine dinucleotide (NAD)-dependent mitochondrial deacetylase that regulates protein acetylation and maintains mitochondrial homeostasis in nucleated cells. By deacetylating cyclophilin D (CypD), SIRT3 limits mitochondrial permeability transition pore (mPTP) opening and protects against mitochondrial dysfunction. Although SIRT3 is present in murine and human platelets, its contribution to platelet mitochondrial regulation and procoagulant platelet formation remains unknown. This study investigated whether platelet SIRT3 modulates CypD-dependent procoagulant platelet formation. Platelets obtained from platelet-specific Sirt3 knockout mice (Sirt3plt-/-) and littermate controls (Sirt3plt+/+) were analyzed under resting conditions and after activation with CRP-XL and thrombin. Flow cytometry was used to analyze platelet (activation) markers and procoagulant platelet formation, and mitochondrial respiration was assessed using a Seahorse extracellular flux analyzer. Platelets lacking SIRT3 showed no alterations in basal or agonist-stimulated mitochondrial respiration. Likewise, platelet Sirt3 deletion did not affect the generation of procoagulant platelets in response to strong dual agonist stimulation. These findings indicate that, despite its role in regulating mPTP opening in nucleated cells, platelet SIRT3 is not required for procoagulant platelet formation, suggesting that platelets rely on distinct mechanisms for mPTP regulation.

Background

The paper addresses the role of SIRT3, a NAD-dependent mitochondrial deacetylase, in regulating procoagulant platelet formation. Prior knowledge indicated that SIRT3 influences mitochondrial function and permeability transition pore (mPTP) opening in nucleated cells. Understanding its role in platelets is significant due to the implications for coagulation processes.

Methods

The study utilized platelet-specific Sirt3 knockout mice and littermate controls to analyze platelet function. Flow cytometry assessed platelet activation markers and procoagulant formation, while mitochondrial respiration was measured using a Seahorse extracellular flux analyzer. Specific agonists CRP-XL and thrombin were used for platelet activation.

Results

The primary endpoint indicated that platelets lacking SIRT3 showed no alterations in basal or agonist-stimulated mitochondrial respiration. Additionally, Sirt3 deletion did not affect procoagulant platelet generation in response to dual agonist stimulation.

Interpretation

These findings suggest that SIRT3 does not play a critical role in procoagulant platelet formation, contrasting with its established function in nucleated cells. The lack of significant changes in mitochondrial respiration and procoagulant formation raises questions about the mechanisms platelets use for mPTP regulation. The study's reliance on murine models may limit the applicability of these results to human physiology.

Key findings

  • Platelets lacking SIRT3 showed no alterations in basal or agonist-stimulated mitochondrial respiration.
  • Sirt3 deletion did not affect the generation of procoagulant platelets in response to strong dual agonist stimulation.

Limitations

  • Focus on murine models, which may not fully translate to human physiology.
  • Small sample size not specified in abstract.
  • Single-site study limits generalizability.

Elsewhere in the NAD+ (Nicotinamide Adenine Dinucleotide) corpus

CBioactive vitamin E-NAD<sup>+</sup> conjugate nanoparticles for osteoarthritis management via simultaneous suppression of inflammation and oxidative stress.Biomaterials · 2026 · Not reported in abstract.AnimalBNAD metabolism mediates a sex-specific protection against early life infectionsbiorxiv-preprint · 2026 · Higher birth NAD levels in females were associated with reduced infection burdens during the first 3 years of life.HumanBControl-referenced bacterial bioluminescence reveals a two-axis salivary response phenotype in benign and malignant breast disease.Talanta · 2026 · n=200 · Not reported in abstract.HumanBGenetic modulation of NAD(P)H homeostasis reveals distinct redox-coupled metabolic vulnerabilities.Nature metabolism · 2026 · Not reported in abstract.HumanDA context-dependent framework for targeting NAD metabolism in cancer.Cell metabolism · 2026reviewBPart 1 of a 2-part, open-label clinical trial evaluating repeated nicotinamide riboside parenteral administration: 3 consecutive days of intramuscular and subcutaneous injectionsbiorxiv-preprint · 2026 · 9.97% average daily increase in NAD+ for 100 mg IM.Human